Suppr超能文献

[3H]马吲哚与心脏去甲肾上腺素转运体的结合:动力学和平衡研究。

Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies.

作者信息

Raffel David M, Chen Wei

机构信息

Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical School, 3480 Kresge III Building, Ann Arbor 48109-0552, USA.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2004 Jul;370(1):9-16. doi: 10.1007/s00210-004-0949-y. Epub 2004 Jul 22.

Abstract

The norepinephrine transporter (NET) is the carrier that drives the neuronal norepinephrine uptake mechanism (uptake1) in mammalian hearts. The radioligand [3H]mazindol binds with high affinity to NET. In this study, the kinetics of [3H]mazindol binding to NET were measured using a rat heart membrane preparation. Results from these studies were used to set up saturation binding assays designed to measure cardiac NET densities (Bmax) and competitive inhibition assays designed to measure inhibitor binding affinities (KI) for NET. Saturation binding assays measured NET densities in rat, rabbit, and canine hearts. Assay reproducibility was assessed and the effect of NaCl concentration on [3H]mazindol binding to NET was studied using membranes from rat and canine hearts. Specificity of [3H]mazindol binding to NET was determined in experiments in which the neurotoxin 6-hydroxydopamine (6-OHDA) was used to selectively destroy cardiac sympathetic nerve terminals in rats. Competitive inhibition studies measured KI values for several NET inhibitors and substrates. In kinetic studies using rat heart membranes, [3H]mazindol exhibited a dissociation rate constant koff=0.0123+/-0.0007 min(-1) and an association rate constant kon=0.0249+/-0.0019 nM(-1)min(-1). In saturation binding assays, [3H]mazindol binding was monophasic and saturable in all cases. Increasing the concentration of NaCl in the assay buffer increased binding affinity significantly, while only modestly increasing Bmax. Injections of 6-OHDA in rats decreased measured cardiac NET Bmax values in a dose-dependent manner, verifying that [3H]mazindol binds specifically to NET from sympathetic nerve terminals. Competitive inhibition studies provided NET inhibitor and substrate KI values consistent with previously reported values. These studies demonstrate the high selectivity of [3H]mazindol binding for the norepinephrine transporter in membrane preparations from mammalian hearts.

摘要

去甲肾上腺素转运体(NET)是驱动哺乳动物心脏中神经元去甲肾上腺素摄取机制(摄取1)的载体。放射性配体[3H]麦角吲哚与NET具有高亲和力结合。在本研究中,使用大鼠心脏膜制剂测量了[3H]麦角吲哚与NET结合的动力学。这些研究结果用于建立旨在测量心脏NET密度(Bmax)的饱和结合测定法和旨在测量抑制剂与NET结合亲和力(KI)的竞争性抑制测定法。饱和结合测定法测量了大鼠、兔子和犬心脏中的NET密度。评估了测定的重现性,并使用大鼠和犬心脏的膜研究了NaCl浓度对[3H]麦角吲哚与NET结合的影响。在使用神经毒素6-羟基多巴胺(6-OHDA)选择性破坏大鼠心脏交感神经末梢的实验中,确定了[3H]麦角吲哚与NET结合的特异性。竞争性抑制研究测量了几种NET抑制剂和底物的KI值。在使用大鼠心脏膜的动力学研究中,[3H]麦角吲哚表现出解离速率常数koff = 0.0123±0.0007 min(-1)和缔合速率常数kon = 0.0249±0.0019 nM(-1)min(-1)。在饱和结合测定中,[3H]麦角吲哚结合在所有情况下均为单相且可饱和。增加测定缓冲液中NaCl的浓度可显著增加结合亲和力,而仅适度增加Bmax。给大鼠注射6-OHDA以剂量依赖性方式降低了测得的心脏NET Bmax值,证实[3H]麦角吲哚特异性结合来自交感神经末梢的NET。竞争性抑制研究提供的NET抑制剂和底物KI值与先前报道的值一致。这些研究证明了[3H]麦角吲哚在哺乳动物心脏膜制剂中对去甲肾上腺素转运体结合的高选择性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验